Literature DB >> 20718941

Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis.

Blake Ferguson1, H Konrad Muller, Herlina Y Handoko, Kiarash Khosrotehrani, Friedrich Beermann, Elke Hacker, H Peter Soyer, Marcus Bosenberg, Graeme J Walker.   

Abstract

We report on a systematic analysis of genotype-specific melanocyte (MC) UVR responses in transgenic mouse melanoma models along with tumour penetrance and comparative histopathology. pRb or p53 pathway mutations cooperated with Nras(Q61K) to transform MCs. We previously reported that MCs migrate from the follicular outer root sheath into the epidermis after neonatal UVR. Here, we found that Arf or p53 loss markedly diminished this response. Despite this, mice carrying these mutations developed melanoma with very early age of onset after neonatal UVR. Cdk4(R24C) did not affect the MC migration. Instead, independent of UVR exposure, interfollicular dermal MCs were more prevalent in Cdk4(R24C) mice. Subsequently, in adulthood, these mutants developed dermal MC proliferations reminiscent of superficial congenital naevi. Two types of melanoma were observed in this model. The location and growth pattern of the first was consistent with derivation from the naevi, while the second appeared to be of deep dermal origin. In animals carrying the Arf or p53 defects, no naevi were detected, with all tumours ostensibly skipping the benign precursor stage in progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718941     DOI: 10.1111/j.1755-148X.2010.00752.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  23 in total

1.  Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.

Authors:  I D Tonks; P Mukhopadhyay; W A Schroder; A Sorolla; A W Mould; H Y Handoko; B Ferguson; H K Muller; P Keith; N K Hayward; G J Walker; G F Kay
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

2.  Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.

Authors:  Chi Luo; Jinghao Sheng; Miaofen G Hu; Frank G Haluska; Rutao Cui; Zhengping Xu; Philip N Tsichlis; Guo-Fu Hu; Philip W Hinds
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

3.  Lack of Evidence From a Transgenic Mouse Model that the Activation and Migration of Melanocytes to the Epidermis after Neonatal UVR Enhances Melanoma Development.

Authors:  Herlina Y Handoko; Mathieu P Rodero; H Konrad Muller; Kiarash Khosrotehrani; Graeme J Walker
Journal:  J Invest Dermatol       Date:  2015-06-02       Impact factor: 8.551

4.  The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.

Authors:  Eric K Lee; Zhaorui Lian; Kurt D'Andrea; Richard Letrero; WeiQi Sheng; Shujing Liu; J Nathaniel Diehl; Dariusz Pytel; Olena Barbash; Lynn Schuchter; Ravi Amaravaradi; Xiaowei Xu; Meenhard Herlyn; Katherine L Nathanson; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

5.  Differential effects of ultraviolet irradiation in neonatal versus adult mice are not explained by defective macrophage or neutrophil infiltration.

Authors:  Mathieu P Rodero; Herlina Y Handoko; Rehan M Villani; Graeme J Walker; Kiarash Khosrotehrani
Journal:  J Invest Dermatol       Date:  2014-02-07       Impact factor: 8.551

6.  Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6.

Authors:  Akihiro Yoshida; Eric K Lee; J Alan Diehl
Journal:  Cancer Res       Date:  2016-03-17       Impact factor: 12.701

7.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

8.  Superficial spreading-like melanoma in Arf(-/-)::Tyr-Nras(Q61K)::K14-Kitl mice: keratinocyte Kit ligand expression sufficient to "translocate" melanomas from dermis to epidermis.

Authors:  Graeme J Walker; H Peter Soyer; Herlina Y Handoko; Blake Ferguson; Takahiro Kunisada; Kiarash Khosrotehrani; Neil F Box; H Konrad Muller
Journal:  J Invest Dermatol       Date:  2011-02-10       Impact factor: 8.551

9.  Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression.

Authors:  B Ferguson; R Ram; H Y Handoko; P Mukhopadhyay; H K Muller; H P Soyer; G Morahan; G J Walker
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

10.  Postnatal lineage mapping of follicular melanocytes with the Tyr::CreER(T) (2) transgene.

Authors:  Melissa L Harris; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2012-12-20       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.